| SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424, 2021 | 3077 | 2021 |
| Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021 | 2492 | 2021 |
| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1085 | 2021 |
| Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study T Nyberg, NM Ferguson, SG Nash, HH Webster, S Flaxman, N Andrews, ... The lancet 399 (10332), 1303-1312, 2022 | 1071 | 2022 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1062 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 915 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 805 | 2022 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 736 | 2021 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 694 | 2021 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 557 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 424 | 2021 |
| SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... Nature microbiology 7 (8), 1161-1179, 2022 | 407 | 2022 |
| Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... Science 371 (6530), 708-712, 2021 | 368 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 338 | 2021 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 296 | 2021 |
| The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages DP Martin, S Weaver, H Tegally, JE San, SD Shank, E Wilkinson, ... Cell 184 (20), 5189-5200. e7, 2021 | 250 | 2021 |
| Tracking the international spread of SARS-CoV-2 lineages B. 1.1. 7 and B. 1.351/501Y-V2 with grinch Á O'Toole, V Hill, OG Pybus, A Watts, II Bogoch, K Khan, JP Messina, ... Wellcome Open Research 6, 2021 | 184 | 2021 |
| Reduced neutralisation of the Delta (B. 1.617. 2) SARS-CoV-2 variant of concern following vaccination C Davis, N Logan, G Tyson, R Orton, WT Harvey, JS Perkins, G Mollett, ... PLoS pathogens 17 (12), e1010022, 2021 | 182 | 2021 |
| An integrated national scale SARS-CoV-2 genomic surveillance network T COVID The Lancet. Microbe 1 (3), e99, 2020 | 173 | 2020 |
| Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B. 1.617. 2): national case-control study H Allen, A Vusirikala, J Flannagan, KA Twohig, A Zaidi, D Chudasama, ... The Lancet Regional Health–Europe 12, 2022 | 172 | 2022 |
